Community pharmacy personnel interventions for smoking cessation by Carson-Chahhoud, K, Livingstone-Banks, J, Sharrad, K, Kopsaftis, Z, Brinn, M, To-A-Nan, R, Bond, C

Group behaviour therapy programmes for smoking cessation. by Stead, L, Carroll, A, Lancaster, T

“… <h4>Background</h4> <p>Group therapy offers individuals the opportunity to learn behavioural techniques for smoking cessation, and to provide each other with mutual support.…”

Managing smoking cessation Authors’ reply to letter by Aveyard, P, West, R

Combined pharmacotherapy and behavioural interventions for smoking cessation. by Stead, L, Lancaster, T

“…AUTHORS' CONCLUSIONS: Interventions that combine pharmacotherapy and behavioural support increase smoking cessation success compared to a minimal intervention or usual care. …”

Placebo-controlled trial of cytisine for smoking cessation. by West, R, Zatonski, W, Cedzynska, M, Lewandowska, D, Pazik, J, Aveyard, P, Stapleton, J

“…CONCLUSIONS: In this single-center study, cytisine was more effective than placebo for smoking cessation. The lower price of cytisine as compared with that of other pharmacotherapies for smoking cessation may make it an affordable treatment to advance smoking cessation globally.…”

Improving smoking cessation approaches at the individual level. by Aveyard, P, Raw, M

Behavioural interventions for smoking cessation: an overview and network meta-analysis by Hartmann-Boyce, J, Hartmann-Boyce, J, Livingstone-Banks, J, Livingstone-Banks, J, Ordonez-Mena, J, Ordonez-Mena, J, Theodoulou, A, Theodoulou, A, Fanshawe, T, Fanshawe, T, Aveyard, P, Aveyard, P, Lindson, N, Lindson, N, Freeman, S, Freeman, S, Sutton, A, Sutton, A

Subjects:

Print-based self-help interventions for smoking cessation by Livingstone-Banks, J, Ordóñez-Mena, J, Hartmann-Boyce, J

“…We found evidence of benefit from standard self‐help materials when there was brief contact that did not include smoking cessation advice (4 studies; n = 2822; RR 1.39, 95% CI 1.03 to 1.88; I² = 0%), but not when self‐help was provided as an adjunct to face‐to‐face smoking cessation advice for all participants (11 studies; n = 5365; RR 0.99, 95% CI 0.76 to 1.28; I² = 32%). …”

Types of knowledge required to personalise smoking cessation letters by Reiter, E, Robertson, R, Osman, L

Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation by Hartmann-Boyce, J, Hong, B, Livingstone-Banks, J, Wheat, H, Fanshawe, TR

“…<p><strong>Background</strong></p> <p>Pharmacotherapies for smoking cessation increase the likelihood of achieving abstinence in a quit attempt. …”

Cannabinoid type 1 receptor antagonists for smoking cessation. by Cahill, K, Ussher, M

“…Selective type 1 cannabinoid (CB1) receptor antagonists may assist with smoking cessation by restoring the balance of the endocannabinoid system, which can be disrupted by prolonged use of nicotine. …”

Smoking cessation for secondary prevention of cardiovascular disease (protocol) by Wu, AD, Hartmann-Boyce, J, Lindson, N, Aveyard, P

“…The objectives are as follows:</p> <p>To examine the impact of smoking cessation on mortality from cardiac disease and major adverse cardiovascular events (MACE), in people with incident coronary heart disease (CHD).…”

Lack of association of OPRM1 genotype and smoking cessation. by Munafò, MR, Johnstone, E, Aveyard, P, Marteau, T

“…<p>INTRODUCTION: Previous studies have reported an association between μ-opioid receptor (OPRM1) genotype and smoking cessation, with some evidence that the strength of this association depends on dose of nicotine replacement therapy (NRT). …”

Strategies to improve smoking cessation rates in primary care by Lindson, N, Pritchard, G, Hong, B, Fanshawe, TR, Pipe, A, Papadakis, S

“…However, the rates at which providers address smoking cessation and the success of that support vary. …”

Nicotine replacement therapy versus control for smoking cessation by Hartmann-Boyce, J, Chepkin, S, Ye, W, Bullen, C, Lancaster, T

“…</p><p> Objectives: To determine the effectiveness and safety of nicotine replacement therapy (NRT), including gum, transdermal patch, intranasal spray and inhaled and oral preparations, for achieving long-term smoking cessation, compared to placebo or 'no NRT' interventions.…”

Review: Various interventions increase smoking cessation rates by Lancaster, T, Stead, L, Silagy, C

The effect of Transtheoretical Model based interventions on smoking cessation. by Aveyard, P, Massey, L, Parsons, A, Manaseki, S, Griffin, C

“…The Transtheoretical Model (TTM) proposes that stage matching improves the effectiveness of behaviour change interventions, such as for smoking cessation. It also proposes that standard smoking cessation interventions are matched to the relatively few smokers in the preparation stage and will not assist the majority of smokers, who are in the precontemplation or contemplation stages. …”

Smoking cessation in pregnancy: What's a man to do? by Ziebland, S, Fuller, A

Print-based self-help interventions for smoking cessation. by Hartmann-Boyce, J, Lancaster, T, Stead, L

“…SELECTION CRITERIA: We included randomized trials of smoking cessation with follow-up of at least six months, where at least one arm tested a print-based self-help intervention. …”

Interventions for preventing weight gain after smoking cessation by Shraim, M, Parsons, A, Aveyard, P, Hajek, P

“…(ii) To examine evidence of interactions between body characteristics, gender, and psychological variables such as fear of weight gain on (a) smoking cessation and (b) weight gain. Copyright © 2006 The Cochrane Collaboration. …”